CagriSema takes the combination approach -- pairing two proven molecules (semaglutide and cagrilintide) in a single injection that produced 20.4% weight loss in phase 3, with 60% of patients losing 20% or more
1 Introduction Parkinsons Disease (PD) is a most recognized syndrome, clinically identifiable by a progression of motor and non-motor symptoms, such as bradykinesia, rigidity, akinesia, dystonia, dysphagia, cognitive impairments, and impairments in gut function and olfaction, among others (Poewe et al., 2017
Nasal drug delivery: new developments and strategies
While the animal model treated with PBS did not show any signs for ROS, high amounts of fluorescence signals in the tissue from the animal treated with NP4 were observed (Supplementary Fig
They may also offer greater convenience and may be easier to scale and distribute than injectable alternatives